RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 Metformin/Pioglitazone/Exenatide Triple Therapy Superior to Stepwise Add-On Conventional Therapy in Newly Diagnosed Type 2 Diabetes
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 11
SP 11
OP 12
DO 10.1177/155989771311007
UL http://mdc.sagepub.com/content/13/11/11.2.abstract
AB This article discusses the results of the Durability of Combination Therapy With Exenatide/Metformin Versus Conventional Therapy in New Onset T2DM study [NCT01107717] that evaluated the effects of a triple-therapy regimen versus stepwise add-on conventional therapy in patients with newly diagnosed type 2 diabetes. In this open-label study, 155 patients were randomized to triple therapy or stepwise add-on conventional therapy, with a goal of achieving an HbA1C of <6.5%.